tiprankstipranks
The Fly

Context Therapeutics appoints PAsternak as Chairman of board of directors

Context Therapeutics appoints PAsternak as Chairman of board of directors

Context Therapeutics (CNTX) announced the appointment of Andy Pasternak as Chairman of its Board of Directors, succeeding Richard Berman, who stepped down from the Board effective January 12, 2025. Most recently, Pasternak served as Executive Vice President, Chief Strategy Officer at Horizon Therapeutics.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1